Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Baird analyst Eric Coldwell upgraded the rating for McKesson Corporation MCK from Neutral to Outperform and raised the price target from $531 to $688. McKesson shares closed at $549.31 on Wednesday. See how other analysts view this stock.
- Raymond James analyst Ric Prentiss upgraded United States Cellular Corporation USM from Market Perform to Outperform and announced a price target of $86. United States Cellular shares closed at $65.15 on Wednesday. See how other analysts view this stock.
- Cantor Fitzgerald analyst Kristen Kluska upgraded the rating for Sarepta Therapeutics, Inc. SRPT from Neutral to Overweight and boosted the price target from $152 to $167. Sarepta Therapeutics shares closed at $127.97 on Wednesday. See how other analysts view this stock.
- JP Morgan analyst Alexei Gogolev upgraded Clearwater Analytics Holdings, Inc. CWAN from Neutral to Overweight and raised the price target from $23 to $33. Clearwater Analytics shares closed at $28.58 on Wednesday. See how other analysts view this stock.
- Wells Fargo analyst Steven Cahall upgraded the rating for Sinclair, Inc. SBGI from Underweight to Equal-Weight and increased the price target from $13 to $19. Sinclair shares closed at $17.41 on Wednesday. See how other analysts view this stock.
Considering buying MCK stock? Here’s what analysts think:
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in